These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6265792)
1. 4',6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Bauer DJ; Selway JW; Batchelor JF; Tisdale M; Caldwell IC; Young DA Nature; 1981 Jul; 292(5821):369-70. PubMed ID: 6265792 [TBL] [Abstract][Full Text] [Related]
2. Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B. Tisdale M; Selway JW J Antimicrob Chemother; 1984 Aug; 14 Suppl A():97-105. PubMed ID: 6092321 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of an early stage of rhinovirus replication by dichloroflavan (BW683C). Tisdale M; Selway JW J Gen Virol; 1983 Apr; 64 (Pt 4)():795-803. PubMed ID: 6300302 [TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime. Ninomiya Y; Aoyama M; Umeda I; Suhara Y; Ishitsuka H Antimicrob Agents Chemother; 1985 Apr; 27(4):595-9. PubMed ID: 2988431 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan. Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152 [TBL] [Abstract][Full Text] [Related]
6. Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds. Ahmad AL; Tyrrell DA Antiviral Res; 1986 Jul; 6(4):241-52. PubMed ID: 3017203 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-rhinovirus activity of 2-styrylchromones. Desideri N; Conti C; Mastromarino P; Mastropaolo F Antivir Chem Chemother; 2000 Nov; 11(6):373-81. PubMed ID: 11227995 [TBL] [Abstract][Full Text] [Related]
8. Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses. Dewindt B; van Eemeren K; Andries K Antiviral Res; 1994 Sep; 25(1):67-72. PubMed ID: 7811059 [TBL] [Abstract][Full Text] [Related]
9. Drug resistant rhinoviruses from the nose of experimentally treated volunteers. Dearden C; al-Nakib W; Andries K; Woestenborghs R; Tyrrell DA Arch Virol; 1989; 109(1-2):71-81. PubMed ID: 2558631 [TBL] [Abstract][Full Text] [Related]
10. Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Phillpotts RJ; Wallace J; Tyrrell DA; Freestone DS; Shepherd WM Arch Virol; 1983; 75(1-2):115-21. PubMed ID: 6338868 [TBL] [Abstract][Full Text] [Related]
11. Studies of rhinovirus resistant to an antiviral chalcone. Ahmad AL; Dowsett AB; Tyrrell DA Antiviral Res; 1987 Aug; 8(1):27-39. PubMed ID: 2825590 [TBL] [Abstract][Full Text] [Related]
12. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions. Al-Nakib W; Tyrrell DA Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones. Desideri N; Mastromarino P; Conti C Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848 [TBL] [Abstract][Full Text] [Related]
14. Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man. Al-Nakib W; Willman J; Higgins PG; Tyrrell DA; Shepherd WM; Freestone DS Arch Virol; 1987; 92(3-4):255-60. PubMed ID: 3545152 [TBL] [Abstract][Full Text] [Related]